Interim Positioning Statements
Statements regarding new drugs, or new licensed indications for established drugs, for which healtheconomy-wide positioning is regarded as urgent before national guidance is issued.
001 IPS (Rev) - Dabigatran Stroke prevention in AF
- stroke
A stroke is caused by a disturbance of blood supply to the brain. Strokes are the leading cause of disability in the UK and the third most common cause of death after cancer and coronary heart disease.